Shogo Kotsuka
Director/Board Member at Biomedica Solution KK
Shogo Kotsuka active positions
| Companies | Position | Start | End |
|---|---|---|---|
Biomedica Solution KK
 Biomedica Solution KK BiotechnologyHealth Technology Part of Tella, Inc., Biomedica Solution KK is a Japanese company that manufactures cell production facilities. | Director/Board Member | 2014-01-31 | - |
Career history of Shogo Kotsuka
Former positions of Shogo Kotsuka
| Companies | Position | Start | End |
|---|---|---|---|
Titan, Inc. (Japan)
 Titan, Inc. (Japan) Data Processing ServicesTechnology Services Titan, Inc. provides imaging solutions and clinical trial support services. The company was founded on May 2, 2013 and is headquartered in Tokyo, Japan. | Director/Board Member | - | - |
| TELLA, INC. | Director/Board Member | 2010-07-31 | - |
| Director of Finance/CFO | 2017-02-28 | - | |
| Investor Relations Contact | 2010-07-31 | - |
Statistics
International
| Japan | 4 |
Operational
| Director/Board Member | 3 |
| Director of Finance/CFO | 1 |
| Investor Relations Contact | 1 |
Sectoral
| Health Technology | 3 |
| Technology Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 3 |
|---|---|
Titan, Inc. (Japan)
Titan, Inc. (Japan) Data Processing ServicesTechnology Services Titan, Inc. provides imaging solutions and clinical trial support services. The company was founded on May 2, 2013 and is headquartered in Tokyo, Japan. | Technology Services |
Biomedica Solution KK
Biomedica Solution KK BiotechnologyHealth Technology Part of Tella, Inc., Biomedica Solution KK is a Japanese company that manufactures cell production facilities. | Health Technology |
tella, Inc.
 tella, Inc. BiotechnologyHealth Technology tella, Inc. engages in research and development of dendritic cell (DC) vaccine therapy. It operates through the following segments: Cell Medicine, Medical Support, and Pharmaceuticals. The Cell Medicine segment provides cancer treatment technology and know-hows centered on dendritic cell vaccine therapy. The Medical Support segment manages contact research organization (CRO) business and offers genetic testing services. The Pharmaceuticals segment deals with the development of dendritic cell vaccine as a cancer treatment. The company was founded by Yuichiro Yazaki on June 24, 2004 and is headquartered in Tokyo, Japan. | Health Technology |
- Stock Market
- Insiders
- Shogo Kotsuka
- Experience
